TEM · Tempus AI, Inc.
Price
Snapshot
50 fields · last close| Market Cap | $13.79B |
| P/E | — |
| Float | 112.8M |
| Beta | 2.50 |
| Volatility 30D | 86.5% |
| Exchange | NASDAQ |
| Sector | Life Sciences Tools & Services |
| Cap tier | Large cap |
| Macro sensitivity | Very High |
| Clavix score | 36.8 |
| Price | 67.74 |
| Change | −10.41% |
| Prev Close | 75.61 |
| Open | 78.73 |
| Day Low | 72.75 |
| Day High | 81.60 |
| Avg Vol | 7 |
| Avg $ Vol | $519.9M |
| 52W High | 90.53 |
| 52W Low | 40.77 |
| 52W Pos | 54.2% |
| From High | −25.17% |
| From Low | +66.15% |
| Max DD 1Y | −50.82% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | −3.83% |
| SMA 50 | −4.82% |
| SMA 200 | +18.70% |
| RSI (14) | 54.6 |
| Vol 90D | 88.5% |
| Vol 1Y | 74.6% |
| 1Y Range | 41–91 |
| Daily bars | 549 |
| Perf Week | −1.31% |
| Perf Month | +5.04% |
| Perf Quarter | +63.94% |
| Perf Half Y | +41.33% |
| Perf Year | −14.77% |
| Perf YTD | +8.63% |
| Prev Day | −10.41% |
| Clavix | D- |
| Debt / Eq | 2.52 |
| Curr Ratio | 3.13 |
| Int Cover | -2.4× |
| FCF Margin | −18.8% |
| Rev Growth | +83.4% |
| Profit | Unprofitable |
| Leverage | High |
| Sector rank | 19 / 19 |
Clavix risk grade
regraded every trading dayTEM grades D-, 36.8 of 100. Steadiest on News Sentiment (63), most exposed on Price Stability (23, weak). 0 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 19 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| TEM | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 2.50 | 1.16 |
| 30-day realized volatilityannualized, from daily closes | 86.5% | 30.3% |
| Max drawdown, past yearworst peak-to-trough fall | −50.8% | — |
| Typical daily movemedian absolute daily change | 2.81% | — |
| Days beyond ±3%of the last 252 sessions | 122 (48%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| TEM | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 2.50 | 1.16 |
| Macro sensitivityrate, dollar and credit exposure bucket | Very High | Moderate 53% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| TEM | |
|---|---|
| 1 week | −1.3% |
| 1 month | +5.0% |
| Year to date | +8.6% |
| 1 year | −14.8% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| TEM | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 12 Oct |
| Average score0 most bearish, 100 most bullish | 73 |
| Bullish · bearisharticles above 60 · below 40 | 27 · 0 |
| Directionarticles whose tone is improving vs worsening | 27 ↑ 0 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| TEM | |
|---|---|
| Revenue growthyear over year | +83.4% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openTempus AI reported third-quarter revenue growth of 23% year over year, reversing four quarters of slowing growth. Minimal residual disease tests, which detect small amounts of disease remaining after treatment, rose 300%, Data & Applications revenue grew 33%, and the company announced partnerships with Bristol Myers Squibb, Moderna, and Merck.
Tempus AI reported upbeat third-quarter results, and analysts increased their forecasts following the release. The article excerpt provides no financial figures, guidance details, or revised forecast values.
Tempus AI reported third-quarter adjusted profit of 7 cents per share, compared with a previously reported loss of 8 cents, beating the consensus expectation of an 11-cent loss. TEM shares were trading higher on Monday.
Tempus AI reported third-quarter earnings of $0.07 per share, beating the analysts' consensus estimate of a $0.09 loss and improving from a $0.11 loss in the same quarter a year earlier. The headline says revenue also beat estimates, but the article body provides no revenue figures.
Tempus AI reported third-quarter 2026 revenue of $411.5 million, up 23% from a year earlier, driven by growth in oncology diagnostics and data-and-applications services. It raised its full-year revenue outlook and reported positive adjusted EBITDA for the quarter.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| CRL | Charles River Laboratories International, Inc. | B- | $15.58B | — | 1.34 | Compare |
| TECH | Bio-Techne Corporation | A | $11.42B | 62.75 | 1.26 | Compare |
| RGEN | Repligen Corporation | B- | $11.39B | 232.35 | 1.17 | Compare |
| RVTY | Revvity, Inc. | B | $17.79B | 75.29 | 1.06 | Compare |
| AVTR | Avantor, Inc. | B- | $10.60B | — | 0.95 | Compare |
| QGEN | QIAGEN N.V. | B+ | $10.50B | 25.58 | 0.57 | Compare |
| MEDP | Medpace Holdings, Inc. | B | $18.37B | 35.60 | 1.11 | Compare |
| BRKR | Bruker Corporation | C+ | $9.72B | — | 1.26 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.